Simultaneously, the high expression of PD-L1 on the surface of NPC tumor cells, and its binding to the inhibitory protein PD-1 produced by CD8 T cells, enable evasion of the adaptive immune system through down-regulation of T-cell response7–10 (Fig. 1). This evidence concerns the gene CD8A and neoplasm.